[Safe oral administration of etoposide: application to pediatric practice].
Legros
M H
MH
Bourget
P
P
Rongeat
S
S
Osmond
S
S
Pein
F
F
Hartmann
O
O
D000284:Administration, Oral; D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004349:Drug Packaging; D004780:Environment, Controlled; D005047:Etoposide / Q000008:administration & dosage* / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D006801:Humans; D007223:Infant; D009369:Neoplasms / Q000188:drug therapy; D010371:Pediatric Nursing / Q000379:methods; D011481:Protective Clothing; D012449:Safety; D013594:Syringes
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide